Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antioxidant Combination for Diabetic Autonomic Neuropathy
NCT00116207Phase 3Completed
- Sponsor
- University of Michigan
- Start
- Jan 2000
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of allopurinol, alpha-lipoic acid, nicotinamide in diabetic autonomic neuropathy (DAN), sponsored by University of Michigan. Started Jan 2000; status: completed.
02
Drugs
allopurinolalpha-lipoic acidnicotinamide
03
Conditions
diabetic autonomic neuropathy (DAN)
Beyond the preview
Go deeper on NCT00116207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00116207.